CA3-31573-82234
4 vaccinations
8 coded responses
52 check-ins
8 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 990 / WA
- Registered
- 2021-01-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
6HR-14340-59615
Child or adolescent in my care · Male · 2022-08-10
Timeline
-
2021-01-21
Dose 1 — Pfizer-BioNTech
-
2021-01-22
Registered in v-safe
- 2021-01-22
- 2021-01-23
- 2021-01-24
- 2021-01-25
- 2021-01-26
- 2021-01-27
- 2021-01-28
- 2021-02-04
- 2021-02-11
-
2021-02-12
Dose 2 — Pfizer-BioNTech
-
2021-02-14
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Good · Site: PainFree text: lymphadenopathyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-15
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: LymphadenopathyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-16
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: LymphadenopathyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-17
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: LymphadenopathyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-18
- 2021-02-19
- 2021-02-26
- 2021-03-05
- 2021-03-12
- 2021-03-19
- 2021-03-26
- 2021-05-14
- 2021-08-13
-
2021-11-27
Dose 3 — Pfizer-BioNTech
- 2021-11-27
- 2021-11-28
-
2021-11-29
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Good · Site: PainFree text: LymphadenopathyMedDRA releases: 2024-11 · check-in free text available
-
2021-11-30
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: GoodFree text: LymphadenopathyMedDRA releases: 2024-11 · check-in free text available
-
2021-12-01
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: GoodFree text: LymphadenopathyMedDRA releases: 2024-11 · check-in free text available
- 2021-12-02
- 2021-12-03
- 2021-12-04
- 2021-12-11
- 2021-12-18
- 2021-12-25
- 2022-01-01
- 2022-01-08
-
2022-02-26
Survey response — 3 months, dose 3MedDRA: Cough, Fatigue, Nasopharyngitis, Oropharyngeal pain, Rhinorrhoea, SARS-CoV-2 test negative — Feeling: Good · Be unable to do your normal daily activitiesFree text: Cold symptoms: sore throat, fatigue, runny nose, cough. Negative for covid x2 and negative for RSV.MedDRA releases: 2024-11 · check-in free text available
- 2022-05-28
-
2022-09-28
Dose 4 — Pfizer-BioNTech
- 2022-09-28
- 2022-09-29
- 2022-09-30
- 2022-10-01
- 2022-10-02
- 2022-10-03
- 2022-10-04
- 2022-10-05
- 2022-10-12
- 2022-10-19
- 2022-10-26
- 2022-11-02
- 2022-11-09
- 2022-12-28
- 2023-03-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-21 | Pfizer-BioNTech | |
| 2 | 2021-02-12 | Pfizer-BioNTech | |
| 3 | 2021-11-27 | Pfizer-BioNTech | No |
| 4 | 2022-09-28 | Pfizer-BioNTech | No |
Free text
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): lymphadenopathy
Systemic reaction (other): Lymphadenopathy
Systemic reaction (other): Lymphadenopathy
Systemic reaction (other): Lymphadenopathy
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Lymphadenopathy
Systemic reaction (other): Lymphadenopathy
Systemic reaction (other): Lymphadenopathy
Release 11 — 3 months, dose 3
Symptoms: Cold symptoms: sore throat, fatigue, runny nose, cough. Negative for covid x2 and negative for RSV.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release